Takeaway
Epilepsy surgery may be an effective long-term treatment for drug-resistant epilepsy in individuals with tuberous sclerosis complex (TSC).
Why this matters
TSC is a rare genetic disease that results in the development of benign tumors in several organs including the central nervous system which, in turn, significantly increases the risk of epilepsy. TSC-associated epilepsy is often drug-resistant and poses challenges for surgical treatment.
Understanding the long-term outcomes of individuals with tuberous sclerosis following epilepsy surgery is necessary to inform clinical practice and ensure the best possible patient outcomes.